Tachipirina Orosolubile 12 Envelopes 500mg,Tachipirina Orosolubile 12 Buste 500mg,ANGELINI SPA

“INDICATIONS: For the symptomatic treatment of mild to moderate pain and fever.
CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to the active substance or to any of the excipients; severe renal failure; alcohol abuse.
DOSAGE: Doses depend on body weight and age. A single dose goes from 10 to 15 mg/kg body weight to 60 to 75 mg/kg for a total daily dose. The time interval between individual dosages depends on the symptoms and on the maximum daily dose. In any case, it should not be less than 4 hours. Should not be used for more than three days without consulting a doctor. 500 mg sachets. 26-40 kg (8-12 years): single dose: 500 mg (1 sachet); daily dose: 1500 mg (3 sachets). > 40 kg (for children over 12 years of age and adults): single dose: 500-1000 mg (1-2 sachets); the maximum daily dose is 3000 mg of (6 sachets of 500 mg). For oral use only. The granule is hired by placing it directly on the tongue and must be swallowed without water. Do not take on a full stomach. Renal or hepatic insufficiency: In patients with insufficiency hepatic and/or renal insufficiency or Gilbert’s syndrome, the dose should be reduced or the time interval between doses should be increased. Patients with renal failure: in patients with gra ve renal failure (creatinine clearance
STORAGE: Do not store at temperatures above 30 degrees C. Store in the original packaging to protect the medicine from light and from um id’.
Precautions: To avoid the risk of overdose, you must ensure that other medications taken at the same time do not contain paracetam oil. should be prescribed with caution to patients with mild to moderate hepatocellular insufficiency (including Gilbert’s sind rome), severe liver failure (Child-Pugh >9), acute hepatitis, in concomitant treatment with drugs that alter liver function, glucose deficiency -6 – phosphate dehydrogenases, anemia and molitor, chronic alcohol abuse, severe renal failure (creatinine clearance and
SIDE EFFECTS: Frequency of adverse reactions: very common (>= 1/10), common (>= 1/100, = 1/1.000, = 1/10.000,”